Mariana Caffaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mariana Caffaro has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Felix Manuel Mottaghy
Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands
1 shared publication - Jens Klotz
Department of Radiation Oncology, RWTH Aachen University, Pauwelsstrasse 30, 52072 Aachen, Germany
1 shared publication - Marc D. Piroth
Department of Radiation Oncology, RWTH Aachen University Hospital, Aachen, Germany
1 shared publication - Michael J. Eble
Department of Radiation Oncology, RWTH Aachen University, 52074 Aachen, Germany
1 shared publication - Michael Pinkawa
Department of Radiation Oncology, Wege Klinik, Bonn, Germany
1 shared publication - Nuria Escobar Corral
Department of Radiation Oncology, RWTH Aachen University, Pauwelsstrasse 30, 52072 Aachen, Germany
1 shared publication
Latest Publications
- Open Access
- 30 January 2012
- Published by Springer Nature in Radiation Oncology
- Vol. 7 (1) , 14
Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without 18F-choline PET-CT detected simultaneous integrated boost
In comparison to the conventional whole-prostate dose escalation, an integrated boost to the macroscopic malignant lesion might potentially improve tumor control rates without increasing toxicity. Quality of life after radiotherapy (RT) with vs. without 18F-choline PET-CT detected simultaneous integrated boost (SIB) was prospectively evaluated in this study.
- 30 January 2012
- Published by Springer Nature in Radiation Oncology
- Vol. 7 (1) , 14
Open AccessDose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without 18F-choline PET-CT detected simultaneous integrated boost
In comparison to the conventional whole-prostate dose escalation, an integrated boost to the macroscopic malignant lesion might potentially improve tumor control rates without increasing toxicity. Quality of life after radiotherapy (RT) with vs. without 18F-choline PET-CT detected simultaneous integrated boost (SIB) was prospectively evaluated in this study.